PREVALENCE OF PHARYNGEAL AND RECTAL CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE INFECTIONS AMONG MSM IN SOFIA, BULGARIA

Authors

  • Ivva Philipova National Center of Infectious and Parasitic Diseases
  • Elena Birindjieva Center for Sexual Health, CheckPointSofia
  • Alexander Milanov Center for Sexual Health, CheckPointSofia
  • Savina Stoitsova National Center of Infectious and Parasitic Diseases

DOI:

https://doi.org/10.58395/pipd.v50i1.88

Keywords:

extragenital infections, Chlamydia trachomatis, Neisseria gonorrhoeae, MSM, Bulgaria

Abstract

Abstract: Sexually transmitted infections (STIs) caused by Chlamydia trachomatis and Neisseria gonorrhoeae continue to be a major public health problem. Although they mainly affect the urogenital tract, N. gonorrhoeae and C. trachomatis can also be found in the pharynx and rectum. As data on extragenital chlamydia and gonorrhea in Bulgaria are still scarce, this study aimed to (1) determine the prevalence of pharyngeal and rectal infections with C. trachomatis and N. gonorrhoeae among men who have sex with men (MSMs) from Sofia and (2) to identify risk factors related to these infections to support screening recommendations based on scientific evidence. One hundred and fifteen MSM aged 16-50 were tested by systematic sampling during a visit to a sexual health center for voluntary and confidential HIV testing in Sofia. A questionnaire was used to collect demographics and risk factors, and clinical material from three anatomical sites: pharynx, rectum, and urogenital tract (first void urine or urethral swab) was examined to detect C. trachomatis and N. gonorrhoeae infections. The prevalence of C. trachomatis was 8.7% in the rectal samples tested, and the prevalence of N. gonorrhoeae was 0.9% and 5.2% in the pharyngeal and rectal samples, respectively. Local symptoms were reported in only 16.6% of rectal gonococcal infections and in 20% of C. trachomatis rectal infections. Patients reporting multiple partners had a significantly higher risk of being positive (OR = 3.8, 95% CI 1.03-14). The risk of HIV-positive MSM and those having unsafe sex was also higher (OR = 1.9 95% CI 0.19-20 and OR = 4.6 95% CI 0.98-21, respectively), but the findings were not statistically significant. Overall, more than 80% of extragenital infections would remain undetected and therefore transmissible if only symptomatic cases were investigated. These results suggest that in Bulgaria HIV-positive MSM and those having multiple sexual partners and unprotected sex would benefit from screening for extragenital STIs. Larger sample surveys could provide a better characterization of risk factors to guide screening choices.

References

Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97(8):548.

Workowski KA. Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2015;61(suppl_8):S759–62.

Chan PA, Robinette A, Montgomery M, Almonte A, Cu-Uvin S, Lonks JR, et al. Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature. Infect Dis Obstet Gynecol. 2016;(2016): 129-145.

Lanjouw E, Ouburg S, De Vries HJ, Stary A, Radcliffe K, Unemo M. 2015 European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS. 2016;27(5):333–48.

Unemo M, Ross JDC, Serwin AB, Gomberg M, Cusini M, Jensen JS. Background review for the ‘2020 European guideline for the diagnosis and treatment of gonorrhoea in adults.’ Int J STD AIDS. 2021;32(2):108–26.

Fifer H, Saunders J, Soni S, Sadiq ST, FitzGerald M. British Association for Sexual Health and HIV national guideline for the management of infection with Neisseria gonorrhoeae (2019). London: British Association for Sexual Health and HIV; 2019.

Fitzgerald N, Anderson ER, Apea V, Curtis H, Goodall L. 2019 British Association of Sexual Health and HIV National Clinical Audit of timelines to be seen, test results and treatment for Chlamydia trachomatis. Int J STD AIDS. 2022;33(6):604–7.

Dukers-Muijrers NHTM, Schachter J, van Liere GAFS, Wolffs PFG, Hoebe CJPA. What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinion. BMC Infect Dis. 2015;15(1):1–13.

Australian Sexual Health Alliance, Australian STI Management Guidelines for Use in Primary Care. Australian Government Department of Health, Darlinghurst, Australia, 2016.

Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm reports Morb Mortal Wkly report Recomm reports. 2015;64(RR-03):1.

Marcus JL, Bernstein KT, Kohn RP, Liska S, Philip SS. Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men. Sex Transm Dis. 2011;38(10):922–4.

De Vries HJC, de Barbeyrac B, De Vrieze NHN, Viset JD, White JA, Vall-Mayans M, et al. 2019 European guideline on the management of lymphogranuloma venereum. J Eur Acad Dermatol Venereol. 2019;33(10):1821–8.

Bachmann LH, Johnson RE, Cheng H, Markowitz L, Papp JR, Palella Jr FJ, et al. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. J Clin Microbiol. 2010;48(5):1827–32.

Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis. 2008;637–42.

Bachmann LH, Johnson RE, Cheng H, Markowitz LE, Papp JR, Hook III EW. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections. J Clin Microbiol. 2009;47(4):902–7.

Goire N, Nissen MD, LeCornec GM, Sloots TP, Whiley DM. A duplex Neisseria gonorrhoeae real-time polymerase chain reaction assay targeting the gonococcal porA pseudogene and multicopy opa genes. Diagn Microbiol Infect Dis. 2008;61(1):6–12.

Hokynar K, Rantakokko-Jalava K, Hakanen A, Havana M, Mannonen L, Jokela P, et al. The Finnish new variant of Chlamydia trachomatis with a single nucleotide polymorphism in the 23S rRNA target escapes detection by the Aptima Combo 2 test. Microorganisms. 2019;7(8):227.

Altman DG. Practical statistics for medical research. CRC press; 1990.

Sheskin DJ. Handbook of parametric and nonparametric statistical procedures. crc Press; 2020.

Tongtoyai J, Todd CS, Chonwattana W, Pattanasin S, Chaikummao S, Varangrat A, et al. Prevalence and correlates of Chlamydia trachomatis and Neisseria gonorrhoeae by anatomic site among urban Thai men who have sex with men. Sex Transm Dis. 2015;42(8):440–9.

Dudareva-Vizule S, Haar K, Sailer A, Wisplinghoff H, Wisplinghoff F, Marcus U, et al. Prevalence of pharyngeal and rectal Chlamydia trachomatis and Neisseria gonorrhoeae infections among men who have sex with men in Germany. Sex Transm Infect. 2014;90(1):46–51.

Lutz AR. Screening for asymptomatic extragenital gonorrhea and chlamydia in men who have sex with men: significance, recommendations, and options for overcoming barriers to testing. LGBT Heal. 2015;2(1):27–34.

. Hui B, Fairley CK, Chen M, Grulich A, Hocking J, Prestage G, et al. Oral and anal sex are key to sustaining gonorrhoea at endemic levels in MSM populations: a mathematical model. Sex Transm Infect. 2015;91(5):365–9.

Annan NT, Sullivan AK, Nori A, Naydenova P, Alexander S, McKenna A, et al. Rectal chlamydia—a reservoir of undiagnosed infection in men who have sex with men. Sex Transm Infect. 2009;85(3):176–9.

Barbee LA. Preparing for an era of untreatable gonorrhea. Curr Opin Infect Dis. 2014;27(3):282.

Cole MJ, Field N, Pitt R, Amato-Gauci AJ, Begovac J, French PD, et al. Substantial underdiagnosis of lymphogranuloma venereum in men who have sex with men in Europe: preliminary findings from a multicentre surveillance pilot. Sex Transm Infect. 2020;96(2):137–42.

den Heijer CDJ, Hoebe CJPA, van Liere GAFS, van Bergen JEAM, Cals JWL, Stals FS, et al. A comprehensive overview of urogenital, anorectal and oropharyngeal Neisseria gonorrhoeae testing and diagnoses among different STI care providers: a cross-sectional study. BMC Infect Dis. 2017;17(1):1–10.

Downloads

Published

2022-10-14

How to Cite

Philipova, I., Birindjieva, E., Milanov, A., & Stoitsova , S. (2022). PREVALENCE OF PHARYNGEAL AND RECTAL CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE INFECTIONS AMONG MSM IN SOFIA, BULGARIA. PROBLEMS of Infectious and Parasitic Diseases, 50(1), 19–24. https://doi.org/10.58395/pipd.v50i1.88

Issue

Section

Articles

Most read articles by the same author(s)